Posts By :

Anne Carter, MA (Cantab)

Anne Carter, MA (Cantab)

How to promote remyelination in MS

2846 1601 Anne Carter, MA (Cantab)

Strategies to promote remyelination was a hot topic at this year’s virtual ACTRIMS/ECTRIMS joint meeting, with three expert presenters each addressing a different aspect of the subject, including the role…

read more

Does the microbiome have a role in MS?

2846 1600 Anne Carter, MA (Cantab)

Can the bacteria living in your gut influence multiple sclerosis (MS) susceptibility and risk of relapse? That was the question Emmanuelle Waubant (University of California, San Francisco, USA) posed during…

read more

Do hormonal changes influence MS in women?

2400 1600 Anne Carter, MA (Cantab)

There is a paradox in multiple sclerosis (MS): females appear to be more susceptible to the disease than males, but also have a better long-term prognosis. Could this be due…

read more

Does COVID-19 affect the brain?

1920 1080 Anne Carter, MA (Cantab)

With EAN going virtual this year, the global SARS-CoV2 pandemic was never far from the attendees’ minds. After a brief overview of the putative mechanisms for SARS-CoV2 accessing the brain,…

read more

Paediatric multiple sclerosis: Adding to our knowledge

1920 1080 Anne Carter, MA (Cantab)

Data suggest that between 2 and 5% of patients with multiple sclerosis (MS) are under 18 years old,1 yet there is only one approved treatment option in this population.2,3 During…

read more

How to choose antiepileptic drug treatment for refractory epilepsy?

1920 1280 Anne Carter, MA (Cantab)

While most patients with epilepsy respond to one or two drugs, it is estimated that 30% develop drug resistance.1 At EAN 2020, Sylvain Rheims (Department of Functional Neurology and Epileptology,…

read more
Brainwork is supported by unrestricted grants from: